Dupilumab and Cutaneous T-Cell Lymphoma: A Call for Vigilance, Not Alarm [0.03%]
杜普利尤单抗与皮肤T细胞淋巴瘤：警惕而非警报
Tiago Torres
Tiago Torres
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials [0.03%]
特纳利珠单抗治疗中重度特应性皮炎成人患者的疗效和安全性：来自III期试验的事后分析
Tiffany Mayo,Jonathan I Silverberg,April Armstrong et al.
Tiffany Mayo et al.
Background: Differences in atopic dermatitis (AD) prevalence, clinical presentation, and pathophysiology have been reported in different ethnic/racial groups; however, clinical trial data for patients with skin of color a...
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations [0.03%]
口服米诺地尔治疗斑秃：风险、获益及建议
Michael M Ong,Yingjoy Li,Shari R Lipner
Michael M Ong
Low-dose oral minoxidil has gained recognition as an off-label treatment for hair loss disorders, including androgenetic alopecia, telogen effluvium, and alopecia areata. Originally developed to treat hypertension, its hair growth-promoting...
Rahaf Zyad Attar,Alice B Gottlieb,Sibel Zehra Aydin
Rahaf Zyad Attar
Enthesitis represents a hallmark feature and central pathological process in psoriatic arthritis and has been proposed as a potential early indicator in patients with psoriasis prior to the onset of clinically apparent psoriatic arthritis. ...
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials [0.03%]
德高宁治疗中重度手部慢性期特应性皮炎疗效和安全性的三期临床试验总结：德尔塔1和德尔塔2多中心随机双盲安慰剂对照试验结果摘要
Robert Bissonnette,Fatima Albreiki,Benjamin D Ehst et al.
Robert Bissonnette et al.
This is a summary of the original article: "Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trial...
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma [0.03%]
头颈部外皮肤鳞状细胞癌的分期系统性能评估
Lindsey M Voller,Kelsey E Hirotsu,Sumaira Z Aasi et al.
Lindsey M Voller et al.
Background: Data are limited regarding the performance of staging systems for non-head and neck cutaneous squamous cell carcinomas (non-HNCSCCs). Objectiv...
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults [0.03%]
Dupilumab治疗中重度特应性皮炎成人及青少年、儿童和婴儿的安全性数据
Richard G Langley,Guy Gherardi,Anna Coleman et al.
Richard G Langley et al.
Background: Atopic dermatitis (AD) significantly affects quality of life in patients of all ages and requires long-term treatment. Dupilumab is approved for uncontrolled moderate-to-severe AD in patients aged ≥ 6 months ...
Skin Ulcers Mimicking Pyoderma Gangrenosum: A Prospective Cohort Study [0.03%]
模拟坏疽性脓皮病的皮肤溃疡：一项前瞻性队列研究
Sarah L Becker,Katelyn Downey,Justin Ng et al.
Sarah L Becker et al.
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry [0.03%]
PEDISTAD登记册中12岁以下中重度特应性皮炎患者系统治疗的现实世界疗效分析
Amy S Paller,Danielle Marcoux,Michele Ramien et al.
Amy S Paller et al.
Background: Atopic dermatitis (AD), a chronic systemic disease, can cause intense skin itching and negatively impact sleep, mood, and quality of life (QoL) for patients and families. ...
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program [0.03%]
有关利特昔替尼的综合安全性分析：来自ALLEGRO临床试验项目的斑秃治疗数据纠正说明
Brett King,Jennifer Soung,Christos Tziotzios et al.
Brett King et al.
Published Erratum
American journal of clinical dermatology. 2025 Sep 11. DOI:10.1007/s40257-025-00976-2 2025